Neurodevelopmental Outcome of Severe Neonatal Hemolytic Hyperbilirubinemia

Abstract

We recruited 128 neonates with hyperbilirubinemia over a 5-year period (1995—2000) to study the short- and long-term effects of hemolytic hyperbilirubinemia on the auditory brainstem pathway and neurodevelopmental status. These children were divided into two groups: (1) a hemolytic group (n = 29; ABO incompatibility [n = 19], Rh incompatibility [n = 1], glucose-6-phosphate dehydrogenase deficiency [n = 8] and both ABO incompatibility and glucose-6-phosphate dehydrogenase deficiency [n = 1]) and (2) a nonhemolytic group ( n = 99). All received phototherapy. Exchange transfusions were performed for four (13.8%) in the hemolytic group and three (3%) in the nonhemolytic group. The brainstem auditory evoked potential was recorded at a mean age of 3.2 months in the hemolytic group and 3.1 months in the nonhemolytic group. Serial brainstem auditory evoked potential assessments were performed until 2 years of age (3 in the hemolytic group and 18 in the nonhemolytic group). All had regular physical, neurologic, visual, and auditory evaluation until 3 years of age. The rate of exchange transfusion was significantly higher in the hemolytic group than in the nonhemolytic group (P< .05). Brainstem auditory evoked potential abnormalities at the initial assessment occurred in three (10.4%) in the hemolytic group (all related to ABO incompatibility) and nine (9.1%) in the nonhemolytic group. At 2 years, the brainstem auditory evoked potential returned to normal except in three cases with a slightly increased hearing threshold (one [3.5%] in the hemolytic group at 60 dB nHL and two [2%] in the nonhemolytic group at 50 dB nHL]). There were no significant differences in the rate of brainstem auditory evoked potential abnormalities at the initial or subsequent assessments between both groups. All except five cases had a normal neurodevelopmental outcome at 3 years (three [two with ABO incompatibility and one with glucose-6-phosphate dehydrogenase deficiency] in the hemolytic group [10.4%] and two [2%] in the nonhemolytic group). All had mild motor delay and hypotonia, which returned to normal at 3 years. The rate of abnormal neurodevelopmental outcome was higher in the hemolytic group than in the nonhemolytic group, although with no significant difference between both groups (P= .08). All five cases in both groups with abnormal neurodevelopment had a normal brainstem auditory evoked potential at the initial assessment. There was no relationship between the abnormal initial brainstem auditory evoked potential and the final neurodevelopmental outcome. The toxic effect of hyperbilirubinemia on the auditory brainstem pathway and neurodevelopmental status in our cohort was transient. The prognosis of neonatal hemolytic hyperbilirubinemia in our Chinese cohort is excellent, possibly owing to an aggressive early-intervention approach. (J Child Neurol 2006;21:474—479; D

Get full access to this article

View all access options for this article.

References

Kiely M. , Drum MA , Kessel K. : Early discharge. Clin Perinatol 1998;25:539—553.

Perstein MA : The late clinical syndrome of poskernicteric encephalopathy. Pediatr Clin North Am 1960;7:665—687.

Hyman CB , Keaster J. , Hanson V. et al: CNS abnormalities after neonatal hemolytic disease and hyperbilirubinemia . Am J Dis Child 1969;117:395—405.

Naeye RL : Amniotic fluid infections, neonatal hyperbilirubinemia and psychomotor impairment . Pediatrics 1978;62:497—503.

Hoyt CB , Bilson FA , Alpins N. : The supranuclear disturbances of gaze in kernicterus. Ann Ophthalmol 1978;10:1487—1492.

Mores A. , Fargasova I. , Minarikova E. : The relation of hyperbilirubinemia in newborns without isoimmunization to kernicterus. Acta Paediatr Scand 1959;48:490—602.

Killander A. , Michaelsson M. , Muller-Eberhard U. , et al: Hyperbilirubinemia in full term newborn infants: A follow-up study. Acta Paediatr Scand 1963;52:481—484.

Fohl E. , Lombos O. : The prognosis of neonatal hemolysis due to A-B-O incompatibility, without exchange transfusion. Ann Paediatr 1964;203:279—287.

Holmes GE , Miller JB , Smith EE : Neonatal bilirubinemia in production of long-term neurological deficits. Am J Dis Child 1968;116:37—43.

10.

Bengtsson B. , Verneholt J. : A follow-up study of hyperbilirubinemia in healthy, full term infants without isoimmunization. Acta Paediatr Scand 1974;63:70—80.

11.

Wishingrad L. , Cornblath M. , Takakuwa P. , et al: Studies of nonhemolytic hyperbilirubinemia in premature infants: Prospective randomized selection for exchange transfusion with observations on the levels of serum bilirubin with and without exchange transfusion and neurological evaluations one year after birth. Pediatrics 1965;36:162—172.

12.

Kaga K. , Kitazumi E. , Kodama K. : Auditory brain stem responses of kernicterus infants. Int J Pediatr Otorhinolaryngol 1979;1:255—264.

13.

Perlman M. , Fainmesser P. , Sohmer H. , et al: Auditory nerve-brainstem evoked responses in hyperbilirubinemic neonates. Pediatrics 1983;72:658—664.

14.

Nakamura H. , Takada S. , Shimabuku R. , et al: Auditory nerve and brainstem responses in newborn infants with hyperbilirubinemia. Pediatrics 1985;75:703—708.

15.

Deltenre P. , Mansbach AL , Bozet C. , et al: Auditory neuropathy: A report on three cases with early onsets and major neonatal illnesses. Electroencephalogr Clin Neurophysiol 1997;104:17—22.

16.

Rance G. , Beer DE , Cone-Wesson B. , et al: Clinical findings for a group of infants and young children with auditory neuropathy. Ear Hear 1999;20:238—252.

17.

Simmons JL , Beauchaine KL : Auditory neuropathy: Case study with hyperbilirubinemia. J Am Acad Audiol 2000;11:337—347.

18.

Nwaesei CG , Van Aerde J , Boyden M. , Perlman M. : Changes in auditory brainstem responses in hyperbilirubinemic infants before and after exchange transfusion. Pediatrics 1984;74:800—803.

19.

Ozmert E. , Eedem G. , Topcu M. , et al: Long-term follow-up of indirect hyperbilirubinemia in full-term Turkish infants. Acta Paediatr 1996;85:1440—1444.

20.

Maisels MJ : Neonatal jaundice, in Avery GB (ed): Neonatology. Philadelphia, JB Lippincott, 1987, 592—593.

21.

Wong V. , Chen WX , Wong KY : Short- and long-term outcome of severe neonatal hyperbilirubinemia. J Child Neurol 2006;21 (4):309-315.

22.

American Academy of Pediatrics, Provisional Committee for Quality Improvement and Subcommittee on Hyperbilirubinemia: Practice parameter : Management of hyperbilirubinemia in the healthy term newborn. Pediatrics 1994;94(4 Pt 1):558-565.

23.

Porter ML , Dennis BL : Hyperbilirubinemia in the term newborn. Am Fam Physician 2002;4:599—607.

24.

Dennery PA , Seidman DS , Stevenson DK : Neonatal hyperbilirubinemia. N Engl J Med 2001;344:581—590.

25.

Newman TB , Maisels MJ : Evaluation and treatment of jaundice in the term newborn: A kinder, gentler approach. Pediatrics 1992;89:809—818.

26.

Bhutani VK , Johnson L. , Sivieri EM : Predictive ability of a predischarge hour-specific serum bilirubin for subsequent significant hyperbilirubinemia in healthy term and near-term newborns. Pediatrics 1999;103:6—14.

27.

Bhutani VK , Gourley GR , Adler S. , et al: Noninvasive measurement of total serum bilirubin in a multiracial predischarge newborn population to assess the risk of severe hyperbilirubinemia . Pediatrics 2000;106:E17.

28.

Hsia DY , Allen FH Jr, Gellis SS , Diamond LK : Erythroblastosis fetalis. VIII. Studies of serum bilirubin in relation to kernicterus. N Engl J Med 1952;247:668—671.

29.

Yilmaz Y. , Degirmenci S. , Akdas F. , et al: Prognostic value of auditory response for neurologic outcome in patients with neonatal indirect hyperbilirubinemia. J Child Neurol 2001;16:772—775.

30.

American Academy on Pediatrics Subcommittee on Neonatal Hyperbilirubinemia : Neonatal jaundice and kernicterus . Pediatrics 2001;108:763—765.

31.

Penn AA , Enzmann DR , Hahn JS , Stevenson DK : Kernicterus in a full term infant. Pediatrics 1994;93(6 Pt 1):1003—1006.

32.

Washington EC , Ector W. , Abboud M. , et al: Hemolytic jaundice due to G6PD deficiency causing kernicterus in a female newborn. South Med J 1995;88:776—779.

33.

Yu MW , Hsiao KJ , Wuu KD , Chen CJ : Association between glucose-6-phosphate dehydrogenase deficiency and neonatal jaundice: Interaction withmultiplerisk factors. Int J Epidemiol 1992 ;21:947-952.

34.

Al-Naama LM , Al-Sadoon IA , Al-Naama MM : Neonatal jaundice and glucose-6-phosphate dehydrogenase deficiency in Basrah. Ann Trop Paediatr 1987;7:134—138.

35.

Kaplan M. , Vreman HJ , Hammerman C. , et al: Combination of ABO blood group incompatibility and glucose-6-phosphate dehydrogenase deficiency: Effect on hemolysis and neonatal hyperbilirubinemia . Acta Paediatr 1998;87:455—457.